2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
70
Prostatic Neoplasms
50
Multiple Myeloma
30
Neoplasm Metastasis
28
Osteoporosis
16
Pain
15
Carcinoma, Non-Small-Cell Lung
11
Neoplasms
10
Lung Neoplasms
8
Osteosarcoma
7
Neoplasms, Plasma Cell
7
Neuroblastoma
6
Carcinoma, Renal Cell
6
Bone Diseases, Metabolic
6
Humoral Hypercalcemia Of Malignancy
5
Bone Neoplasms
5
Fractures, Bone
4
Bone Diseases
4
Triple Negative Breast Neoplasms
3
Sarcoma, Ewing
3
Sarcoma
3
Lymphoma
3
Kidney Neoplasms
3
Uterine Cervical Neoplasms
2
Spinal Cord Compression
2
Small Cell Lung Carcinoma
2
Rhabdomyosarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pleural Effusion, Malignant
2
Ovarian Neoplasms
2
Interventions
Oxaliplatin
295
Capecitabine
209
Fluorouracil
183
Cisplatin
172
Docetaxel
140
S 1 (combination)
135
Paclitaxel
128
Leucovorin
117
Irinotecan
110
pembrolizumab
104
Trastuzumab
76
Nivolumab
59
apatinib
57
Drug Therapy
52
sintilimab
46
Surgical Procedures, Operative
45
Ramucirumab
40
Radiotherapy
40
Bevacizumab
37
Hyperthermic Intraperitoneal Chemotherapy
34
Epirubicin
32
titanium silicide
31
tislelizumab
31
Carboplatin
31
Gastrectomy
28
Cyclophosphamide
27
XELOX
25
Tegafur
24
Folfox protocol
23
Albumin-Bound Paclitaxel
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Zoledronic Acid
×
Clear all
NCT06759064
2025-11-19
IPIZA
Qilu Hospital of Shandong University
Phase 1/2
Recruiting
24 enrolled